This new drug could change how we treat one of the deadliest cancers - PBS
Source:PBS
The overall survival rate for people who got daraxonrasib was 13.2 months, nearly double the 6.7 months people survived on standard chemotherapy alone.
Related Articles
How Real Is the Nocebo Effect? - Skeptic
Can your mind make you sick? Carol Tavris dissects the “nocebo effect”—how negative expectations …
Biallelic variants in RNU2-2 cause the most prevalent known recessive neurodevelopmental disorder - nature.com
An analysis of rare disease cohorts from the UK, the USA, Italy and the Netherlands identifies a …
The holy grail of fitness, according to a sports medicine doctor - Axios
It’s a boring truth underscored by new research.
Ask a Vet: Five dog vaccines you shouldn’t skip - The Washington Post
Leptospirosis, parvo and other core vaccines can help keep your dog healthy.